IFITM3 and schizophrenia: Given that IFITM3 expression is up-regulated in the brains of patients with schizophrenia [93,94,95] and ASD [96], it is proposed that IFITM3 might be a novel drug target for the treatment of these neurodevelopmental disorders [40,95].